As part of our commitment to helping you achieve your healthiest finances, we are pleased to announce the launch of nine new Custom Target Date Fund investment options in the Johnson & Johnson Savings Plan, available starting September 30, 2019.
More information will follow in the coming weeks, including a detailed brochure and other information to help you make informed decisions about your options. Eligible retirees have been notified via emails or letters, and you can click here for a copy of the first notification for reference.
On July 12 an article
was posted by Bloomberg about JOHNSON’S® Baby Powder. You can access our
position about this article on factsabouttalc.com
The J&J MyStore website has been updated based on
customer feedback and best-in-class ecommerce practices. With a fresh
look and new features, including a wish list and mini cart, the MyStore update
makes for a simpler and more enjoyable shopping experience all from the same
URL as the old site (www.JJMyStore.com).
To access the new MyStore, all customers will need to complete a first-time login.
From the time people are born, through their school years, first
dates, broken bones, cancer diagnoses and more, Johnson & Johnson is there
restoring confidence, comfort and hope. We are a company guided by the values
set forth in Our Credo, with a bold ambition expressed in Our Purpose: We blend
heart, science and ingenuity to profoundly change the trajectory of health for humanity. Read More.
This message is being shared now that the first opioid court trial involving Johnson & Johnson has started in the United States. Linked below is a message by our General Counsel, Mike Ullmann, which was written and initially distributed to employees in the U.S. prior to the start of the trial.
We also have launched a new microsite that shares facts and context related to our prescription opioid medications and our legal response. This microsite will serve as our public hub of information related to these issues in the weeks ahead. We will continue to add statements, documents and other information when appropriate.
Read More from Michael Ullmann
Do YOU know someone who has taken a break from their STEM2D career and wants to return to work?
The Johnson & Johnson Re-Ignite program is currently recruiting for cohorts in many global locations. The program is open to professionals with experience in their STEM2D (Science, Technology, Engineering, Math, Manufacturing, Design) related field who have taken a career break from a STEM2D role for two or more years.
What is Re-Ignite?
A return to work program designed to bring talent with a 2 year+ career break across all technical positions back to the workforce. During their short-term returnship, all Re-Ignite Associates will receive in-depth onboarding & training materials, a large support structure, mentors, technical peers, and alumni guidance. At the conclusion of their returnship period, which varies in length by geography, all Re-Ignite associates will be considered for a full-time role at J&J. Check out our Re-Ignite program on careers.jnj.com to learn more.
Re-Ignite a Colleague’s STEM Career
The Re-Ignite program is ideal for people returning to professional pursuits after leaving the workforce for a variety of reasons, like military service, family obligations, entrepreneurial ventures, education, or other pursuits. If you know someone who may be a great fit, share this article with them!
Consumers deserve a clearer picture of what they can expect to pay at the pharmacy. At Janssen, we have long been a leader in transparency. When the current Administration’s American Patients First Blueprint issued in May of last year proposed including list price information in direct-to-consumer TV ads, we saw an opportunity to envision – and implement – additional transparency that would enable patients to make more informed decisions.
That’s why, later this quarter, we will begin including information about the cost of our medicines in pharmaceutical DTC TV advertising, starting with our most frequently prescribed medicine, an oral anti-coagulant. We will include both the list price and potential patient out-of-pocket costs.
We spoke with many consumers and patients to understand what pricing information would be most relevant to them. Their input not only shaped how we responded to the Administration’s DTC TV advertising proposal, it also suggested a common-sense path forward that we believe will give patients clearer, and more valuable, information about the cost of the medicines we advertise on TV.
As we begin to introduce cost information into our DTC TV ads, we will be thoughtful and patient-focused in our approach, communicating both list price and out-of-pocket cost information in ways that enable patients and consumers to understand this information easily. We’re starting with our most widely prescribed medicine so we can assess how the price and cost information is received by a broad range of people. We will take into account patient and consumer feedback in guiding roll-out to additional medicines we advertise on TV.
Our approach to DTC TV ads builds on our strong support for PhRMA’s revised advertising principles. In accordance with these principles, member companies will direct patients to online information about the costs of medicines advertised on television. An important self-imposed industry standard, the principles reflect PhRMA member companies’ commitment to more transparency about medicine costs. Importantly, the principles recognize that being transparent about list price alone is not enough.
Transparency is fundamental to achieving a more sustainable, results-based health system that delivers greater access to care at a more manageable cost. Later this quarter, we’ll provide more up-to-date information about our responsible business practices that put patients first, including how we invest our resources, price our medicines, and help people who need Janssen medicines get access to them, in our third annual Janssen U.S. Transparency Report.
In taking this step today, we are continuing our legacy of leadership in transparency by voluntarily sharing meaningful, relevant information about what people can expect to pay for their medicines in our DTC TV advertising.
Since 2011, Johnson & Johnson has partnered with nationwide nonprofit American Corporate Partners (ACP) to engage business leaders as mentors to veterans making the transition from the military to the corporate workforce.
ACP pairs Mentors and Protégés in one-on-one, yearlong mentorships that are facilitated by ACP staff. Volunteer Mentors assist with topics such as career exploration, résumé review, interview preparation, networking, career coaching, entrepreneurship, and overall professional development.
For more than 10 years, ACP has provided transitioning servicemembers and veterans with customized mentorships with experienced business professionals across the country. More than 13,000 veterans have completed an ACP mentorship.
Today, with support from J&J, ACP is proud to be offering career mentorships to active duty military spouse, and we invite YOU to serve as a mentor for these spouses.
Whether you have previous mentoring experience, a military connection, or simply want to give back to the military community, military spouses are eager to learn from your expertise. Volunteer to assist with topics including career exploration, resume review, interview preparation and more.
Learn more about ACP, its mentorship programs and apply as a Mentor here!
Dear J&J Colleagues,
Today we continue to actively defend the safety of our talc and the integrity
and reputation of our company with key stakeholders, including the media,
investors, consumers and you, our employees.
Last night, Alex was featured on CNBC's Mad
Money setting the record straight. During the segment, Alex
stressed the safety of talc and the ethics of our company. While we continue to
see stories perpetuating the false information published by Reuters last
Friday, we are now seeing more balanced stories appearing in several outlets
including Bloomberg, BBC, CNBC and Business Insider.
Today we are launching our second advertisement called, “What We Know” to clarify any false information
and to ensure our stakeholders have access to the important information about
the safety of talc.
For example, we know that we have consistently acted with transparency in this
matter. We have always cooperated fully and openly with the FDA and other
regulators, making our talc available for testing.
We know, and as Our Credo reminds us, patients come first, and nothing is more
important than the health and safety of the mothers, fathers and all others who
use our products. We know that Johnson’s Baby Powder does not contain asbestos
and we test every single lot to ensure it.
Many of you have asked how you can engage in the defense of our company through
your social channels. You can share content that J&J has published on
Twitter, Facebook or LinkedIn. Here is additional information on how and what you can
share on social media.
Thank you for all you do as stewards of the reputation of Johnson & Johnson
and your continued commitment to health.Michael Sneed
Executive Vice President
Global Corporate Affairs and Chief Communication Officer
Dear J&J Colleagues,I’m writing to ensure that as employees, you can be confident that Johnson & Johnson’s baby powder is safe and asbestos-free. In fact, the talc in our baby powder is the purest, safest pharmaceutical-grade talc on earth.As your Chairman and CEO, I take very seriously and personally the recent media reports that say otherwise. I know many of you feel the same way. Given all that has transpired, it’s important for me to set the record straight and answer your questions.I trust you know that these media stories are one-sided and false. And because of this, we are publicly challenging them, defending the facts on talc and defending the integrity of our company. I want you to be as informed as possible, so below are links to the statements we have made in response to the media articles: Our response to the Reuters article.Our statement on The New York Times article. I am pleased to share that we’ve begun an aggressive digital, social and print advertising campaign, directing the public to review the facts for themselves at www.factsabouttalc.com.I want to assure you that the executive team and I are actively engaging with the media and investment community to counter these false articles.As we move forward, I strongly encourage you to visit the www.factsabouttalc.com website and reference the other resources available, so you understand the truth about talc and the integrity of Johnson & Johnson. Feel free to share your comments and questions on my blog. Thank you for leading with and living into Our Credo and helping to ensure that good health is within reach of everyone everywhere!
Please click on the video to hear some words from Alex Gorsky
Turn over a new leaf with your voluntary benefits from Added Benefits®. As a retiree of Johnson & Johnson, you could enjoy special savings not available to the general public on reliable coverage for your automobiles, home1, personal property, and pets. Plus, you can access special discounts at your favorite retailers.
Call 1-888-332-4134 or visit www.AddedBenefitsJJ.com to participate.
For more information, please click here.
Dear Johnson & Johnson Retiree,
The J&J North America Government Affairs department is pleased to announce a new grassroots advocacy website designed for employees and retirees. The Johnson & Johnson Political Information Network JJPIN site is your one-stop resource for the company’s current federal and state legislative priorities, your legislators and nonpartisan voting information. Also, as appropriate, you may be asked to voluntarily weigh in with your elected representative about an important piece of legislation with significant impact to our business. Please take a moment to visit the site at: www.jjpin.com. Registration is as easy as signing onto the online company store. Your voice makes a difference. Thank you.
NEW! As a retiree, you now have access to more than 25 Johnson & Johnson fitness centers. Read more.
This website is solely for retirees of the Johnson & Johnson Family of Companies, and will help you reconnect with colleagues, stay up to date on the latest Johnson & Johnson news, and take advantage of everything available to you as a retiree.
For over 125 years, the employees of the Johnson & Johnson Family of Companies have worked to advance the health and well-being of people throughout the world. Thank you for your contributions in pursuit of this goal.
NYSE : JNJ
Your Equity Awards
ARAG Legal Insurance Plan